Correspondence 0001493152-26-025198 from ENvue Medical, Inc. (FEED)
ENvue Medical, Inc.
Date: May 26, 2026 · CIK: 0001326706 · Accession: 0001493152-26-025198
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-296001
Letter
ENvue Medical, Inc.
Pruitt Place
Tyler TX 75703
May 26, 2026
VIA EDGAR
Division of Corporation Finance
Office of Industrial Applications and Services
U.S. Securities and Exchange Commission
Washington, D.C. 20549
Attention: Conlon Danberg
Re: ENvue Medical, Inc.
Registration Statement on Form S-3
Filed on May 18, 2026
File No. 333-296001 (as amended, the “Registration Statement”)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 of the Rules and Regulations of the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended, ENvue Medical, Inc. (the “Company”), hereby respectfully requests acceleration of the effective date of the Registration Statement, so that it may become effective at 4:00 p.m., Eastern Time, on May 28, 2026, or as soon thereafter as practicable.
Should any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Haynes and Boone, LLP, attention: Alla Digilova, Esq. at (212) 659-4993.
Very
truly yours,
ENVUE
MEDICAL, Inc.
Show Raw Text
CORRESP
1
filename1.htm
ENvue
Medical, Inc.
969
Pruitt Place
Tyler
TX 75703
May
26, 2026
VIA
EDGAR
Division
of Corporation Finance
Office
of Industrial Applications and Services
U.S.
Securities and Exchange Commission
Washington,
D.C. 20549
Attention:
Conlon Danberg
Re:
ENvue
Medical, Inc.
Registration
Statement on Form S-3
Filed
on May 18, 2026
File
No. 333-296001 (as amended, the “Registration Statement”)
Request
for Acceleration
Ladies
and Gentlemen:
Pursuant
to Rule 461 of the Rules and Regulations of the Securities and Exchange Commission (the “Commission”) under
the Securities Act of 1933, as amended, ENvue Medical, Inc. (the “Company”), hereby respectfully requests acceleration
of the effective date of the Registration Statement, so that it may become effective at 4:00 p.m., Eastern Time, on May 28, 2026, or
as soon thereafter as practicable.
Should
any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Haynes
and Boone, LLP, attention: Alla Digilova, Esq. at (212) 659-4993.
Very
truly yours,
ENVUE
MEDICAL, Inc.
By:
/s/
Doron Besser, M.D.
Doron
Besser, M.D.
Chief
Executive Officer
cc:
Alla
Digilova, Esq., Haynes and Boone, LLP